Recent Security Class Actions

Outset Medical Inc. Common Stock (NASDAQ: OM)

22 Days left to seek lead plaintiff status.

Company Name:Outset Medical Inc. Common Stock
Stock Symbol:NASDAQ: OM
Class Period Start:08/01/2022
Class Period End (inclusive):08/07/2024
Filing Deadline:10/28/2024

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, the Complaint alleges Defendants failed to disclose to investors: (1) the Tablo products were marketed for continuous renal replacement therapy, which is not one of the indications approved by the FDA; (2) that, as a result, Outset Medical was reasonably likely to submit an additional 510(k) application for the Tablo products; (3) that there was a substantial risk that the Company would cease sales of the Tablo products pending FDA approval of additional indications; (4) that Outset Medical lacked the sales team and process to execute on the ramp of Tablo sales; (5) that, as a result of the foregoing, the Company’s revenue growth would be adversely impacted; and (6) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Outset Medical Inc. Common Stock (NASDAQ: OM) Claim Form

Name(Required)
Address
This field is for validation purposes and should be left unchanged.